SERPINF1 and diabetic retinopathy: To test the efficacy of PEDF in counteracting the retinal neovascularization characteristic of diabetic retinopathy, we established a gene therapy protocol based on the transfer to the mouse retina of the human PEDF gene using adeno-associated viral vectors of serotype 2 (AAV2), which efficiently transduce the retina [18].